Bausch & Lomb (BLCO) Liabilities and Shareholders Equity (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Liabilities and Shareholders Equity came in at $13.9 billion in Q2 2026, little changed YoY from $13.8 billion in Q2 2025, and up 0.57% on a QoQ basis from $13.8 billion in Q1 2026.
Bausch & Lomb (BLCO) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $13.9 billion in Q2 2026.
- Quarterly Liabilities and Shareholders Equity changed 0.2% year-over-year to $13.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $55.5 billion (up 2.3% YoY) and the FY2025 annual result came in at $14.0 billion, up 4.11% from the prior year.
- Liabilities and Shareholders Equity climbed to $13.9 billion in Q2 2026, from $13.8 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $14.0 billion in Q4 2025 to a low of $10.7 billion in Q3 2022.
- A 5-year average of $12.7 billion and a median of $13.4 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity rose 22.18% — and 2026, when it gained 0.2%.
- Tracing BLCO's Liabilities and Shareholders Equity over 5 years: stood at $11.1 billion in 2022, then advanced by 20.62% to $13.4 billion in 2023, then gained by 0.2% to $13.5 billion in 2024, then increased by 4.11% to $14.0 billion in 2025, then fell by 1.16% to $13.9 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $13.9 billion (Q2 2026), $13.8 billion (Q1 2026), and $14.0 billion (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.79 Bn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | 13.86 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.86 Bn |
| Mar 31, 2026 | 13.78 Bn |
| Dec 31, 2025 | 14.02 Bn |
| Sep 30, 2025 | 13.83 Bn |
| Jun 30, 2025 | 13.83 Bn |
| Mar 31, 2025 | 13.43 Bn |
| Dec 31, 2024 | 13.47 Bn |
| Sep 30, 2024 | 13.52 Bn |
| Jun 30, 2024 | 13.25 Bn |
| Mar 31, 2024 | 13.29 Bn |
| Dec 31, 2023 | 13.44 Bn |
| Sep 30, 2023 | 13.07 Bn |
| Jun 30, 2023 | 11.32 Bn |
| Mar 31, 2023 | 11.17 Bn |
| Dec 31, 2022 | 11.14 Bn |
| Sep 30, 2022 | 10.70 Bn |
| Jun 30, 2022 | 11.00 Bn |
| Mar 31, 2022 | 10.91 Bn |
| Dec 31, 2021 | 10.82 Bn |